Infectious Disease & Vaccines

The best scientific presentations are not just about the science. The delivery matters too.

Pioneering approaches transform vaccine technologies and shape the future of disease prevention.

Researchers precisely engineered an antibody to better treat respiratory depression due to overdose from increasingly prevalent synthetic opioids.

Inhibitors of an enzyme essential for schistosomiasis parasitic infection effectively combat the condition in mice.

Last year, the USDA conditionally approved an oral vaccine for mice to reduce the transmission of Lyme disease to humans.

Using a machine learning approach, researchers discovered how to make mouse macrophages resistant to tuberculosis infection.

A novel system for procuring leaf samples leads researchers to a new amino acid and a promising antifungal drug candidate.

Since antibiotics tend to have negative side effects on the gut, researchers sought an alternative in an unexpected place: yogurt.

A new mechanism for inhibiting membrane proteins could pave the way for more effective antibiotics.

Some infectious diseases require unique modifications to the traditional vaccine development approach.  

Pathogens invade mucosal surfaces like the nose, but typical vaccines don't mount an immune response there. Newly engineered mucosal vaccines, however, do.

Epithelial cells partner with tissue-resident memory cells to protect the lung during Streptococcus pneumoniae infection.